Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796–802.
Article
CAS
PubMed
Google Scholar
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27. doi:10.1056/NEJMoa021641.
Article
PubMed
Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
Article
CAS
PubMed
Google Scholar
ICO Information Centre on HPV and Cancer. Human Papillomavirus and related cancers. Institut Català d’Oncologia. Fact Sheet 2014 (Dec 15). http://www.hpvcentre.net/statistics/reports/MAR_FS.pdf 2014.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10(4):321–2.
Article
PubMed
Google Scholar
Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278–85. doi:10.1002/ijc.20244.
Article
CAS
PubMed
Google Scholar
Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24 Suppl 3:S3/26–34. doi:10.1016/j.vaccine.2006.05.026.
Google Scholar
de Villiers EM, Wagner D, Schneider A, Wesch H, Miklaw H, Wahrendorf J, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet. 1987;2(8561):703–6.
Article
PubMed
Google Scholar
McClelland RS, Ndinya-Achola JO, Baeten JM. Re: distinguishing the temporal association between women’s intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol. 2007;165(4):474–5. doi:10.1093/aje/kwk101. author reply 5-6.
Article
PubMed
Google Scholar
Ferenczy A, Coutlee F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ. 2003;169(5):431–4.
PubMed Central
PubMed
Google Scholar
Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20(18):2337–44. doi:10.1097/01.aids.0000253361.63578.14.
Article
PubMed
Google Scholar
Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577–86. doi:10.1093/jnci/dji073.
Article
PubMed
Google Scholar
Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120–30. doi:10.1093/jnci/djp205.
Article
PubMed Central
PubMed
Google Scholar
De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008;17(6):545–54. doi:10.1097/CEJ.0b013e3282f75ea1.
Article
PubMed
Google Scholar
Rapport national 2014. Mise en œuvre de la déclaration politique sur le VIH/sida. Royaume du Maroc, Ministère de la Santé. www.unaids.org/sites/default/files/country/documents//MAR_narrative_report_2014.pdf. 2014.
Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human. Cancer Cells. 1989;7:209–14.
CAS
Google Scholar
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–15. doi:10.1016/s1470-2045(12)70137-7.
Article
PubMed
Google Scholar
Alhamany Z, El Mzibri M, Kharbach A, Malihy A, Abouqal R, Jaddi H, et al. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program. J Infect Dev Ctries. 2010;4(11):732–9.
PubMed
Google Scholar
Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer. 1998;75(4):546–54.
Article
CAS
PubMed
Google Scholar
EL Gnaoui N, Benchakroun N, Benider A, Hassar M, Saile R, Benoma H. Typing of human papillomavirus and evaluation of risk factors associated with cervical cancer in Morocco. Eur J Sci Res. 2009;31:229–36.
Google Scholar
Amrani M, Lalaoui K, El Mzibri M, Lazo P, Belabbas MA. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol. 2003;27(3):286–95.
Article
PubMed
Google Scholar
Birrou K, Tagajdid R, Elannaz H, Elkochri S, Abi R, Zouhdi M, et al. Human papillomavirus genotype prevalence and distribution among Moroccan pregnant women. Int J Res Med Sci. 2015;3:95–9.
Google Scholar
Bennani B, Bennis S, Nejjari C, Ouafik L, Melhouf MA, El Rhazi K, et al. Correlates of HPV: a cross-sectional study in women with normal cytology in north-central Morocco. J Infect Dev Ctries. 2012;6(7):543–50.
Article
PubMed
Google Scholar
Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001;93(17):1325–30.
Article
CAS
PubMed
Google Scholar
Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer. 2000;87(2):221–7.
Article
CAS
PubMed
Google Scholar
Rolon PA, Smith JS, Munoz N, Klug SJ, Herrero R, Bosch X, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer. 2000;85(4):486–91.
Article
CAS
PubMed
Google Scholar
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26 Suppl 10:K1–16. doi:10.1016/j.vaccine.2008.05.064.
Article
PubMed
Google Scholar
Usubutun A, Alemany L, Kucukali T, Ayhan A, Yuce K, de Sanjose S, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol. 2009;28(6):541–8. doi:10.1097/PGP.0b013e3181aaba0d.
Article
PubMed
Google Scholar
Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste. Costa Rica J Infect Dis. 2005;191(11):1796–807. doi:10.1086/428850.
Article
PubMed
Google Scholar
Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer. 2008;122(2):428–32. doi:10.1002/ijc.23092.
Article
CAS
PubMed
Google Scholar
Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, et al. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer. 2008;122(2):424–7. doi:10.1002/ijc.23093.
Article
CAS
PubMed
Google Scholar
Meftah el khair M, Ait Mhand R, Mzibri ME, Ennaji MM. Risk factors of invasive cervical cancer in Morocco. Cell Mol Biol (Noisy-le-Grand). 2009;55:OL1175–85.
Google Scholar
Carrillo-Garcia A, Ponce-de-Leon-Rosales S, Cantu-de-Leon D, Fragoso-Ontiveros V, Martinez-Ramirez I, Orozco-Colin A, et al. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. Gynecol Oncol. 2014;134(3):534–9. doi:10.1016/j.ygyno.2014.06.018.
Article
PubMed
Google Scholar
Chaturvedi AK, Katki HA, Hildesheim A, Rodriguez AC, Quint W, Schiffman M, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis. 2011;203(7):910–20. doi:10.1093/infdis/jiq139.
Article
PubMed Central
PubMed
Google Scholar
Yang Z, Cuzick J, Hunt WC, Wheeler CM. Concurrence of multiple human papillomavirus infections in a large US population-based cohort. Am J Epidemiol. 2014;180(11):1066–75. doi:10.1093/aje/kwu267.
Article
PubMed
Google Scholar
van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol. 2002;156(2):158–64.
Article
PubMed
Google Scholar
Stuardo V, Agusti C, Godinez JM, Montoliu A, Torne A, Tarrats A, et al. Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer. PLoS One. 2012;7(10):e47755. doi:10.1371/journal.pone.0047755.
Article
PubMed Central
CAS
PubMed
Google Scholar
Louie KS, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health. 2009;14(10):1287–302. doi:10.1111/j.1365-3156.2009.02372.x.
Article
PubMed
Google Scholar
Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet. 1999;65(2):171–81.
Article
CAS
PubMed
Google Scholar
Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91(3):226–36.
Article
CAS
PubMed
Google Scholar
Del Mistro A, Chieco BL. HPV-related neoplasias in HIV-infected individuals. Eur J Cancer. 2001;37(10):1227–35.
Article
PubMed
Google Scholar
Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, et al. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. BMC Public Health. 2015;15:453. doi:10.1186/s12889-015-1779-1.
Article
PubMed Central
PubMed
Google Scholar